NCT04809974View on ClinicalTrials.gov

Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 28, 2021

Primary Completion Date

October 5, 2023

Study Completion Date

February 23, 2024

Conditions
Covid19Sequelae of; InfectionCognitive Symptom
Interventions
DRUG

Niagen

The intervention consists of taking Niagen and completing all tasks divided into 6 visits.

Trial Locations (1)

02129

Clinical Translational Research Unit, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT04809974 - Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 | Biotech Hunter | Biotech Hunter